Rhaeos: Funding, Investors & Team (Sep 2026)
The first wearable shunt monitor in the world, Rhaeos, uses a cutting-edge thermal biosensor to enhance the quality of care for hydrocephalus patients. Rhaeos was created at Northwestern University in partnership with Dr. John Rogers, the McCormick School of Engineering, the Feinberg School of Medicine, and the Kellogg School of Management. It is a unique example of a multidisciplinary translational effort addressing a critical clinical need.
Rhaeos has raised $12.0M across 2 funding rounds on record, the most recent an undisclosed round of $1.5M announced in Oct 2023.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Rhaeos Company Profile and Key Stats
Latest funding round on record: Oct 2023.
Rhaeos Funding Rounds
Rhaeos raised $10.5M in a Series A announced in Feb 2023.
8 months later, an undisclosed round of $1.5M was announced in Oct 2023.
Rhaeos Founders and Leadership Team
No contact details are on record for this team yet.
Rhaeos Funding Compared to Other Biotechnology Startups
Rhaeos' latest round of $1.5M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Rhaeos in Biotechnology and Evanston
Companies Similar to Rhaeos
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Rhaeos Funding FAQs
What does Rhaeos do?
The first wearable shunt monitor in the world, Rhaeos, uses a cutting-edge thermal biosensor to enhance the quality of care for hydrocephalus patients. Rhaeos was created at Northwestern University in partnership with Dr. John Rogers, the McCormick School of Engineering, the Feinberg School of Medicine, and the Kellogg School of Management. It is a unique example of a multidisciplinary translational effort addressing a critical clinical need.
How much funding has Rhaeos raised?
Rhaeos has raised $12.0M across 2 rounds on record. The most recent is an undisclosed round of $1.5M announced in Oct 2023.
When did Rhaeos last raise funding?
Rhaeos' most recent funding round on record is an undisclosed round of $1.5M, announced in Oct 2023.
Who founded Rhaeos?
FundedIQ lists Siddharth Krishnan (Founder) at Rhaeos.
Who is the CEO of Rhaeos?
Anna Lisa Somera is listed as CEO at Rhaeos.
Where is Rhaeos headquartered?
Rhaeos is based in Evanston, Illinois, United States.
How many employees does Rhaeos have?
Rhaeos is in the 1-10 employee band.
How does Rhaeos' funding compare to other Biotechnology startups?
Rhaeos' latest round of $1.5M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Rhaeos Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Rhaeos is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.